Senti Biosciences, INC. (SNTI) — 10-K Filings
All 10-K filings from Senti Biosciences, INC.. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
Senti Bio's SENTI-202 Shows Promise in AML, Secures FDA Designations
— Mar 27, 2026 Risk: high
Senti Biosciences, Inc. (SNTI) is a clinical-stage biotechnology company focused on developing next-generation cell and gene therapies using its proprietary gen -
Senti Biosciences Files 2024 10-K
— Mar 20, 2025 Risk: medium
Senti Biosciences, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, previously known as Dynamics Special Purpose Corp., is in the -
Senti Biosciences, Inc. Files 2023 Annual Report on Form 10-K
— Mar 21, 2024 Risk:
Senti Biosciences, Inc. (SNTI) filed a Annual Report (10-K) with the SEC on March 21, 2024. Senti Biosciences, Inc. filed its annual report for the fiscal year
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX